Total
0
Shares
MyFiziq (ASX:MYQ) - CEO & Executive Director, Vlado Bosanac
CEO & Executive Director, Vlado Bosanac
Source: TechInvest Magazine
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • MyFiziq (MYQ) has announced that the newly-integrated Evolt360 is now available on the Apple App Store
  • This app is an integration of digital health company Evolt’s namesake app and MyFiziq’s body scanning technology
  • The FDA-approved device tracks activity, body composition and nutrition, with the newly-added feature of body scanning
  • Evolt customers will be able to download access to MyFiziq’s tech through the Evolt Active app
  • Evolt has committed to targeting an initial 100,000 active users in the first 12 months and MyFiziq will receive $2.99 per month per user
  • Company shares are up 9.09 per cent and are trading for 30 cents each

MyFiziq (MYQ) has announced that the newly-integrated Evolt360 is now available on the Apple App Store.

This marks the official launch of Evolt’s Evolt Active application with an in-app body scanning feature using MyFiziq’s technology.

Evolt is an intelligent body scanning technology that has been purchased by the likes of F45, Anytime Fitness, HCF and KPMG. These health and fitness companies realise the more in-depth insight that Evolt can bring into their members’ health and fitness journeys.

The scans performed by the existing Evolt tech are made available to consumers for between $30 and $50 per scan.

The Evolt technology is also a U.S. Food and Drug Administration (FDA)-approved medical grade device.

The newly-released Evolt Active app is integrated with MyFiziq’s technology. The company’s technology is intended to extend the reach of Evolt to their 500,000 consumers.

With the new integration, Evolt customers can download access to the MyFiziq technology, through the Evolt Active app.

Evolt is a digital health and wellness company that has developed solutions that can track activity, body composition and nutrition. But now with the integration, Evolt’s app can now track changes in body circumference as an additional data set.

“The application has been through rigorous testing in readiness for this launch. I am pleased to say the application is performing well on all fronts. The look and feel of the application is a credit to both teams. We are looking forward to supporting Evolt with its launch, users, downloads, and usage,” CEO Vlado Bosanac said.

Evolt has committed to targeting an initial 100,000 active users onto the joint offering in the first 12 months and MyFiziq will receive $2.99 per month per user.

If the initial target user numbers are achieved, MyFiziq will meet an initial break-even position, based on current monthly burn.

Evolt Active has just been released on iOS however it will be made available on Android at some point.

Company shares are up 9.09 per cent and are trading for 30 cents each at 1:44 pm AEST.

MYQ by the numbers
More From The Market Herald
ClearVue Technologies (ASX:CPV) - Non Executive Director, John Downes

" ClearVue Technologies (ASX:CPV) appoints LendLease’s John Downes to board

Smart building materials company ClearVue Technologies (CPV) has appointed LendLease’s (LLC) John Downes as Non-Executive Director.
ELMO Software (ASX:ELO) - CEO, Danny Lessem

" ELMO Software (ASX:ELO) launches new COVID-19 tracking module

ELMO Software (ELO) has launched a new module, enabling businesses to track employee’s COVID-19 vaccination and test status.

" Vection Technologies (ASX:VR1) launches upgraded virtual reality design tool

Vection Technologies (VR1) shares are trading in the green after launching an upgrade to its virtual reality design application MinDesk.
Damstra (ASX:DTC) - Chairman, Johannes Risseeuw

" Damstra (ASX:DTC) completes $18m TIKS Solutions buy

Damstra (DTC) has completed the acquisition of software-as-a-service (SaaS) business TIKS Solutions.